logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Om Prakash Goel

This inventor holds 35 USPTO granted patents and 3 published patent applications, primarily in Antiviral Agents. Top assignees: Warner-Lambert Company, Jiva Pharma Inc., Ssv Therapeutics, Inc.. Active years: 1978-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Om Prakash Goel. Retrieved from https://idiyas.com/inventor/om-prakash-goel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 35 

% Patents Active = 68.6

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 132(Granted Patents)


Location History:

  • Canton, MI (US) (1978)
  • Ann Arbor, MI (US) (1987 - 2021)

Company Filing History:

goldMedal19 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal8 out of 8 
 
Jiva Pharma Inc.
 patents
bronzeMedal7 out of 7 
 
Ssv Therapeutics, Inc.
 patents
4. 1 out of 834,659 
Other
 patents

Years Active: 1978-2021

Loading Chart...
Areas of Expertise:
Antiviral Agents
Thiazolidinediones
Omega-3 Derivatives
Diabetes Treatments
Carnitine Conjugates
Asymmetric Hydrogenation
NSAID Derivatives
Prebiotics
Insulin Sensitizers
Hypercholesterolemia
Prodrugs
Natural Amino Acids
35 patents (USPTO):Explore Patents
1. 11202774 - 5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents (2021-12-21),
2. 10646477 - 5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents (2020-05-12),
3. 10125078 - NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators (2018-11-13),
4. 9815777 - Metformin salts to treat Type2 diabetes (2017-11-14),
5. 9808497 - Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements (2017-11-07),
6. 9688613 - Omegabalins, GABA derivatives of omega-3 polyunsaturated acids, their formulations and methods of use (2017-06-27),
7. 9540307 - Statins of omega-3 polyunsaturated acids for treating hypercholesterolemia (2017-01-10),
8. 9364465 - Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes (2016-06-14),
9. 8247398 - Zinc complexes of natural amino acids for treating elevated copper caused toxicities (2012-08-21),
10. 8049038 - Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses (2011-11-01),
11. 7977511 - Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses (2011-07-12),
12. 7893289 - Adamantanamines and neramexane salts of thiomolybdic and thiotungstic acids (2011-02-22),
13. 7777071 - Production of carnitine conjugate intermediates (2010-08-17),
14. 7718696 - Methods of treating diabetes using carnitine conjugates as dual prodrugs (2010-05-18),
15. 7414156 - [object Object] (2008-08-19),

Title: The Innovative Journey of Om Prakash Goel

Introduction: Om Prakash Goel, a distinguished inventor based in Ann Arbor, MI, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Om Prakash Goel holds several patents in various technological domains, showcasing his versatility and creativity in inventing novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Om Prakash Goel has established himself as a visionary inventor, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout his career, Om Prakash Goel has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge sharing.

Conclusion: Om Prakash Goel's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his reputation as a pioneering inventor in the tech industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…